SCHEMBL19686344

SCHEMBL19686344

Cc1cn(-c2ccccc2)c(=O)c2ccc(-n3c4ccc(N(c5ccccc5)c5ccccc5)cc4c4cc(N(c5ccccc5)c5ccccc5)ccc43)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.36
ESRRA P11474 1/20 0.36
ESR2 Q92731 1/20 0.36
KDM4E B2RXH2 5/20 0.35
LMNA P02545 3/20 0.34
ALDH1A1 P00352 3/20 0.34
APP P05067 1/20 0.34
SCN2B O60939 1/20 0.34
SCN1A P35498 1/20 0.34
SCN1B Q07699 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN9A Q15858 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 2/20 0.33
MAPK8 P45983 1/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
TP53 P04637 2/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685830 0.96 APP (0.34) ESR1ESRRAESR2KDM4ELMNA
SCHEMBL19686144 0.89 KDM4E (0.42) ESR1ESRRAESR2KDM4ELMNA
SCHEMBL19685723 0.88 BRD4 (0.36) LMNAAPPSMN1; SMN2HPGDHTT
SCHEMBL19686143 0.86 KDM4E (0.43) ESR1ESRRAESR2KDM4ELMNA
SCHEMBL19685827 0.85 SCN2B (0.37) KDM4ELMNAALDH1A1APPSCN2B
SCHEMBL19686045 0.84 KDM4E (0.39) ESR1ESRRAESR2KDM4ELMNA
SCHEMBL19685738 0.84 MAPK8 (0.35) LMNAALDH1A1APPSCN2BSCN1A
SCHEMBL19686028 0.83 APP (0.35) LMNAALDH1A1APPSMN1; SMN2HPGD
SCHEMBL19686345 0.83 ESRRA (0.43) ESR1ESRRAESR2KDM4ELMNA
SCHEMBL19686042 0.81 KDM4E (0.42) ESR1ESRRAESR2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS ESR1 503/4885ESRRA 1108/4885ESR2 808/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS ESR1 503/4885ESRRA 1108/4885ESR2 808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.